| Mr Mohammad Hassan Shokouh-amiri, MD | |
|
272 Hospital Rd, Chillicothe, OH 45601-9031 | |
| (740) 779-7658 | |
| (740) 779-7323 |
| Full Name | Mr Mohammad Hassan Shokouh-amiri |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 28 Years |
| Location | 272 Hospital Rd, Chillicothe, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265659130 | NPI | - | NPPES |
| 0403840 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 35139201 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adena Regional Medical Center | Chillicothe, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Osu Pathology Services, Llc | 4587569983 | 60 |
News Archive
Researchers at UT Southwestern Medical Center have developed what they believe to be the first clinical application of a new imaging technique to diagnose brain tumors.
A new study shows that African American women coinfected with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) are less likely to die from liver disease than Caucasian or Hispanic women.
Furiex Pharmaceuticals, Inc. announced today that the United States Patent and Trademark Office issued a patent on May 18, 2010, for the method for treatment of premature ejaculation using dapoxetine. Furiex developed dapoxetine in collaboration with Alza Corporation and its affiliates. U.S. Patent No. 7,718,705 includes claims directed to dosing dapoxetine on an as-needed basis, capturing the advantage dapoxetine has over other compounds in the same class, which require a pre-loading period for efficacy.
Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced results from a second study of QPI-1007, a neuroprotective siRNA drug, in rat ocular hypertension model of glaucoma, conducted by Prof. Adriana Di Polo of the Department of Pathology and Cell Biology, Universite de Montreal.
› Verified 8 days ago
| Entity Name | Osu Pathology Services, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083713820 PECOS PAC ID: 4587569983 Enrollment ID: O20031126000571 |
News Archive
Researchers at UT Southwestern Medical Center have developed what they believe to be the first clinical application of a new imaging technique to diagnose brain tumors.
A new study shows that African American women coinfected with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) are less likely to die from liver disease than Caucasian or Hispanic women.
Furiex Pharmaceuticals, Inc. announced today that the United States Patent and Trademark Office issued a patent on May 18, 2010, for the method for treatment of premature ejaculation using dapoxetine. Furiex developed dapoxetine in collaboration with Alza Corporation and its affiliates. U.S. Patent No. 7,718,705 includes claims directed to dosing dapoxetine on an as-needed basis, capturing the advantage dapoxetine has over other compounds in the same class, which require a pre-loading period for efficacy.
Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced results from a second study of QPI-1007, a neuroprotective siRNA drug, in rat ocular hypertension model of glaucoma, conducted by Prof. Adriana Di Polo of the Department of Pathology and Cell Biology, Universite de Montreal.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Mohammad Hassan Shokouh-amiri, MD 700 Ackerman Rd Ste 2120, Columbus, OH 43202-1559 Ph: (740) 779-7658 | Mr Mohammad Hassan Shokouh-amiri, MD 272 Hospital Rd, Chillicothe, OH 45601-9031 Ph: (740) 779-7658 |
News Archive
Researchers at UT Southwestern Medical Center have developed what they believe to be the first clinical application of a new imaging technique to diagnose brain tumors.
A new study shows that African American women coinfected with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) are less likely to die from liver disease than Caucasian or Hispanic women.
Furiex Pharmaceuticals, Inc. announced today that the United States Patent and Trademark Office issued a patent on May 18, 2010, for the method for treatment of premature ejaculation using dapoxetine. Furiex developed dapoxetine in collaboration with Alza Corporation and its affiliates. U.S. Patent No. 7,718,705 includes claims directed to dosing dapoxetine on an as-needed basis, capturing the advantage dapoxetine has over other compounds in the same class, which require a pre-loading period for efficacy.
Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced results from a second study of QPI-1007, a neuroprotective siRNA drug, in rat ocular hypertension model of glaucoma, conducted by Prof. Adriana Di Polo of the Department of Pathology and Cell Biology, Universite de Montreal.
› Verified 8 days ago
Dr. Nancy V Rodway, MD Pathology Medicare: Medicare Enrolled Practice Location: 272 Hospital Rd, Chillicothe, OH 45601 Phone: 740-779-7250 Fax: 740-779-7329 | |
Byron D Smith, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 272 Hospital Rd, Adena Regional Medical Center, Chillicothe, OH 45601 Phone: 740-779-7657 |